Alwadei Ali, Alnaami Ibrahim, Alenazy Kawthar, Marei Amal, BaHammam Leenh O, Nasser Sameh, Alswilem Abdullah Mansour, Maklad Ahmed, Shehata Shehata F, Alqahtani Mohammad Salem, Al-Shahrani Abdulelah, Balbaid Ali
Department of Neurosurgery, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.
Division of Neurosurgery, Department of Surgery, College of Medicine, King Khalid University, Abha 62523, Saudi Arabia.
Brain Sci. 2022 Sep 2;12(9):1186. doi: 10.3390/brainsci12091186.
Purpose: Although the association between residential location and survival in patients with different cancer types has been established, the conclusions are contentious, and the underlying mechanisms remain unknown. Here, we reviewed the impact of residence on the survival of patients with glioblastoma (GBM). Methods: We conducted a retrospective study to compare the impact of rural and urban residence on the survival rates of patients with GBM diagnosed in Riyadh City and outside Riyadh. All patients in this study were treated in a tertiary care hospital, and their survival rates were analyzed in relation to their residence and other related factors, namely radiotherapy timing. Results: Overall, 125 patients were included: 61 from Riyadh City and 64 from outside. The majority of patients in both groups were aged >50 years (p = 0.814). There was no statistically significant difference between the groups in the Eastern Cooperative Oncology Group Performance Status (p = 0.430), seizure (p = 0.858), or initiation timing of radiotherapy (p = 0.781). Furthermore, the median survival rate in the Riyadh group versus the other group was 14.4 months and 12.2 months, respectively, with no statistical significance (p = 0.187). Conclusions: Our study showed that residential location had no significant effect on GBM prognosis. However, further studies with a larger sample size are required to delineate the other factors of referral within the healthcare system to facilitate the management of these patients within a specific timeframe.
尽管不同癌症类型患者的居住地点与生存率之间的关联已得到证实,但其结论存在争议,潜在机制仍不明晰。在此,我们回顾了居住地点对胶质母细胞瘤(GBM)患者生存率的影响。方法:我们进行了一项回顾性研究,以比较农村和城市居住环境对利雅得市及利雅得市以外地区诊断为GBM的患者生存率的影响。本研究中的所有患者均在一家三级护理医院接受治疗,并根据其居住地点和其他相关因素(即放疗时机)分析其生存率。结果:总体而言,共纳入125例患者:61例来自利雅得市,64例来自其他地区。两组中的大多数患者年龄>50岁(p = 0.814)。两组在东部肿瘤协作组体能状态(p = 0.430)、癫痫发作(p = 0.858)或放疗开始时机(p = 0.781)方面无统计学显著差异。此外,利雅得组与另一组的中位生存率分别为14.4个月和12.2个月,无统计学显著性(p = 0.187)。结论:我们的研究表明,居住地点对GBM预后无显著影响。然而,需要进一步开展更大样本量的研究,以明确医疗系统内转诊的其他因素,以便在特定时间范围内对这些患者进行管理。